Members of the European Parliament from all political groups voted for tightening proposed rules against food speculation, but fell short of the votes needed to force the Commission to amend them.
Insufficient innovation and a lack of access to affordable medicines are major barriers to achieving the right to health in low- and middle-income countries.
The European Commission is putting the interests of multinational drug companies above those of millions of people with no access to affordable life-saving medicines, warn Oxfam and Health Action International.